184 related articles for article (PubMed ID: 22461023)
1. Effect of peripheral administration of cholecystokinin on food intake in apolipoprotein AIV knockout mice.
Yoshimichi G; Lo CC; Tamashiro KL; Ma L; Lee DM; Begg DP; Liu M; Sakai RR; Woods SC; Yoshimatsu H; Tso P
Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(11):G1336-42. PubMed ID: 22461023
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein AIV requires cholecystokinin and vagal nerves to suppress food intake.
Lo CC; Langhans W; Georgievsky M; Arnold M; Caldwell JL; Cheng S; Liu M; Woods SC; Tso P
Endocrinology; 2012 Dec; 153(12):5857-65. PubMed ID: 23027805
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal CCK and fourth-intraventricular Apo AIV require both peripheral and NTS CCK1R to reduce food intake in male rats.
Lo CC; Davidson WS; Hibbard SK; Georgievsky M; Lee A; Tso P; Woods SC
Endocrinology; 2014 May; 155(5):1700-7. PubMed ID: 24564397
[TBL] [Abstract][Full Text] [Related]
4. Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake.
Lo CM; Zhang DM; Pearson K; Ma L; Sun W; Sakai RR; Davidson WS; Liu M; Raybould HE; Woods SC; Tso P
Am J Physiol Regul Integr Comp Physiol; 2007 Oct; 293(4):R1490-4. PubMed ID: 17634201
[TBL] [Abstract][Full Text] [Related]
5. Effect of intraperitoneal and intravenous administration of cholecystokinin-8 and apolipoprotein AIV on intestinal lymphatic CCK-8 and apo AIV concentration.
Lo CM; Xu M; Yang Q; Zheng S; Carey KM; Tubb MR; Davidson WS; Liu M; Woods SC; Tso P
Am J Physiol Regul Integr Comp Physiol; 2009 Jan; 296(1):R43-50. PubMed ID: 19020287
[TBL] [Abstract][Full Text] [Related]
6. Energy homeostasis in apolipoprotein AIV and cholecystokinin-deficient mice.
Weng J; Lou D; Benoit SC; Coschigano N; Woods SC; Tso P; Lo CC
Am J Physiol Regul Integr Comp Physiol; 2017 Nov; 313(5):R535-R548. PubMed ID: 28768657
[TBL] [Abstract][Full Text] [Related]
7. Expression and regulation of cholecystokinin and cholecystokinin receptors in rat nodose and dorsal root ganglia.
Broberger C; Holmberg K; Shi TJ; Dockray G; Hökfelt T
Brain Res; 2001 Jun; 903(1-2):128-40. PubMed ID: 11382396
[TBL] [Abstract][Full Text] [Related]
8. Loss of cholecystokinin and glucagon-like peptide-1-induced satiation in mice lacking serotonin 2C receptors.
Asarian L
Am J Physiol Regul Integr Comp Physiol; 2009 Jan; 296(1):R51-6. PubMed ID: 19005016
[TBL] [Abstract][Full Text] [Related]
9. Estradiol enhances cholecystokinin-dependent lipid-induced satiation and activates estrogen receptor-alpha-expressing cells in the nucleus tractus solitarius of ovariectomized rats.
Asarian L; Geary N
Endocrinology; 2007 Dec; 148(12):5656-66. PubMed ID: 17823256
[TBL] [Abstract][Full Text] [Related]
10. Normal feeding and body weight in Fischer 344 rats lacking the cholecystokinin-1 receptor gene.
Blevins JE; Overduin J; Fuller JM; Cummings DE; Matsumoto K; Moralejo DH
Brain Res; 2009 Feb; 1255():98-112. PubMed ID: 19111529
[TBL] [Abstract][Full Text] [Related]
11. Increased short-term food satiation and sensitivity to cholecystokinin in neurotrophin-4 knock-in mice.
Chi MM; Fan G; Fox EA
Am J Physiol Regul Integr Comp Physiol; 2004 Nov; 287(5):R1044-53. PubMed ID: 15297267
[TBL] [Abstract][Full Text] [Related]
12. Impaired satiation and increased feeding behaviour in the triple-transgenic Alzheimer's disease mouse model.
Adebakin A; Bradley J; Gümüsgöz S; Waters EJ; Lawrence CB
PLoS One; 2012; 7(10):e45179. PubMed ID: 23056194
[TBL] [Abstract][Full Text] [Related]
13. Reduction of food intake by cholecystokinin requires activation of hindbrain NMDA-type glutamate receptors.
Wright J; Campos C; Herzog T; Covasa M; Czaja K; Ritter RC
Am J Physiol Regul Integr Comp Physiol; 2011 Aug; 301(2):R448-55. PubMed ID: 21562094
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein A-IV enhances cholecystokinnin secretion.
Zhan J; Weng J; Hunt BG; Sean Davidson W; Liu M; Lo CC
Physiol Behav; 2018 May; 188():11-17. PubMed ID: 29378187
[TBL] [Abstract][Full Text] [Related]
15. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
Lieverse RJ; Jansen JB; Masclee AA; Rovati LC; Lamers CB
Gut; 1994 Apr; 35(4):501-5. PubMed ID: 8174988
[TBL] [Abstract][Full Text] [Related]
16. Why does the gut choose apolipoprotein B48 but not B100 for chylomicron formation?
Lo CM; Nordskog BK; Nauli AM; Zheng S; Vonlehmden SB; Yang Q; Lee D; Swift LL; Davidson NO; Tso P
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G344-52. PubMed ID: 18006607
[TBL] [Abstract][Full Text] [Related]
17. Characterization of mice lacking the gene for cholecystokinin.
Lo CM; Samuelson LC; Chambers JB; King A; Heiman J; Jandacek RJ; Sakai RR; Benoit SC; Raybould HE; Woods SC; Tso P
Am J Physiol Regul Integr Comp Physiol; 2008 Mar; 294(3):R803-10. PubMed ID: 18160529
[TBL] [Abstract][Full Text] [Related]
18. Urocortins and cholecystokinin-8 act synergistically to increase satiation in lean but not obese mice: involvement of corticotropin-releasing factor receptor-2 pathway.
Gourcerol G; Wang L; Wang YH; Million M; Taché Y
Endocrinology; 2007 Dec; 148(12):6115-23. PubMed ID: 17932219
[TBL] [Abstract][Full Text] [Related]
19. Infant satiety depends on transient expression of cholecystokinin-1 receptors on ependymal cells lining the third ventricle in mice.
Ozaki T; Mohammad S; Morioka E; Takiguchi S; Ikeda M
J Physiol; 2013 Mar; 591(5):1295-312. PubMed ID: 23266937
[TBL] [Abstract][Full Text] [Related]
20. Estradiol increases the anorectic effect of central apolipoprotein A-IV.
Shen L; Wang DQ; Lo CM; Tso P; Davidson WS; Woods SC; Liu M
Endocrinology; 2010 Jul; 151(7):3163-8. PubMed ID: 20484461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
